Lighthouse Investment Partners’s Regeneron Pharmaceuticals REGN Stock Holding History

Lighthouse Investment Partners’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-485	Closed	-$375K	–	911
2026 Q1	$375K	Sell	485 -280	-37%	-$214K	0.01%	562
2025 Q4	$590K	Sell	765 -2,435	-76%	-$1.65M	0.02%	570
2025 Q3	$1.8M	Hold	3,200	–	–	0.05%	352
2025 Q2	$1.68M	Buy	+3,200	New	+$1.79M	0.06%	329
2025 Q1	–	Sell	-3,300	Closed	-$2.35M	–	613
2024 Q4	$2.35M	Buy	+3,300	New	+$2.77M	0.08%	268
2024 Q3	–	Sell	-12,536	Closed	-$13.2M	–	537
2024 Q2	$13.2M	Buy	12,536 +7,348	+142%	+$7.12M	0.53%	38
2024 Q1	$4.99M	Buy	+5,188	New	+$4.93M	0.23%	131

Other funds holding REGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Lighthouse Investment Partners's REGN Position: Q2 2026 in Review

Lighthouse Investment Partners sold out of Regeneron Pharmaceuticals (REGN) in Q2 2026, closing a stake of 485 shares — an estimated $375K sold.

Lighthouse Investment Partners first reported a position in REGN in Q1 2024 and held it in 7 quarters. The position peaked at $13.2M in Q2 2024. 1,340 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

Lighthouse Investment Partners reported no remaining Regeneron Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Lighthouse Investment Partners sold 485 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $375K.
Lighthouse Investment Partners first reported a position in Regeneron Pharmaceuticals in Q1 2024 and held it in 7 quarters.
Lighthouse Investment Partners's Regeneron Pharmaceuticals position peaked at $13.2M in Q2 2024.
1,340 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Lighthouse Investment Partners's 13F filing for Q2 2026, filed 14 Aug 2026.